Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials

Most academic precision oncology programs have been designed to facilitate enrollment of patients in early clinical trials with matched targeted agents. Over the last decade, major changes were seen both in the targetable molecular alteration landscape and in drug development trends. In this article...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Autores principales: Dienstmann, Rodrigo, Garralda, Elena, Aguilar, Susana, Sala, Gemma, Viaplana, Cristina, Ruiz-Pace, Fiorella, González-Zorelle, Jenifer, Grazia LoGiacco, Deborah, Ogbah, Zighereda, Ramos Masdeu, Laia, Mancuso, Francesco, Fasani, Roberta, Jimenez, Jose, Martinez, Paola, Oaknin, Ana, Saura, Cristina, Oliveira, Mafalda, Balmaña, Judith, Carles, Joan, Macarulla, Teresa, Elez, Elena, Alsina, Maria, Braña, Irene, Felip, Enriqueta, Tabernero, Josep, Rodon, Jordi, Nuciforo, Paolo, Vivancos, Ana
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2020
Materias:
Special Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446427/
https://ncbi.nlm.nih.gov/pubmed/32923891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00398
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares